Silencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1, nuclear factor-kappaB, p53, bax, and p27 levels.
about
Nano-encapsulation of arsenic trioxide enhances efficacy against murine lymphoma model while minimizing its impact on ovarian reserve in vitro and in vivoBlockade of fatty acid synthase triggers significant apoptosis in mantle cell lymphomaSmall molecule inhibitors of bcl-2 family proteins for pancreatic cancer therapyGfer is a critical regulator of HSC proliferation.Hematologic malignancies: newer strategies to counter the BCL-2 protein.Broad targeting of resistance to apoptosis in cancer.MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid MalignanciesTW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and induces apoptosis in pancreatic cancer: involvement of Notch-1 signaling pathway.FBXO10 deficiency and BTK activation upregulate BCL2 expression in mantle cell lymphoma.Preclinical activity of 8-chloroadenosine with mantle cell lymphoma: roles of energy depletion and inhibition of DNA and RNA synthesis.Mantle cell lymphoma in cyclin D1 transgenic mice with Bim-deficient B cells.Recent trends in cancer drug resistance reversal strategies using nanoparticles.Non-Hodgkin's B-cell lymphoma: advances in molecular strategies targeting drug resistance.Fenofibrate induces effective apoptosis in mantle cell lymphoma by inhibiting the TNFalpha/NF-kappaB signaling axis.Interleukin-21 effectively induces apoptosis in mantle cell lymphoma through a STAT1-dependent mechanism.Apogossypolone induces apoptosis and autophagy in nasopharyngeal carcinoma cells in an in vitro and in vivo study.Novel targeted therapeutics for mantle cell lymphoma--what's on the horizon?Reversal of lung cancer multidrug resistance by pH-responsive micelleplexes mediating co-delivery of siRNA and paclitaxel.Mesenchymal stromal cells protect mantle cell lymphoma cells from spontaneous and drug-induced apoptosis through secretion of B-cell activating factor and activation of the canonical and non-canonical nuclear factor κB pathways.Heparin-binding EGF-like factor augments esophageal epithelial cell proliferation, migration and inhibits TRAIL-mediated apoptosis via EGFR/MAPK signaling.Recent Advances in Comprehending the Signaling Pathways Involved in the Progression of Breast Cancer.
P2860
Q28488457-E35D20C1-B245-4FA1-93E3-9AD52A75D07CQ28730808-402D22CF-5EC0-4AE3-A6F9-B1E7C22448A0Q35099238-38243DC6-5C44-422C-ADDF-3DCEEF264619Q35592116-BF786039-CB7F-4D0B-8BE8-327894A5D665Q35979110-DFBFBC8F-8585-4783-9896-014379081180Q36483749-92461E7F-C726-4E86-B8BB-2B9B149DD947Q36602853-EE292B40-883B-4A86-ACA0-1018F29964BFQ37232979-F3718418-1E62-46DE-B464-EDCF5CF3B930Q37404843-9DF56EF3-40AF-4558-9D49-775C2418C055Q37424558-4AEDCBEE-B70D-48FF-BCBD-D9722A8965F2Q37564773-94035498-BA0D-4F54-95BC-A95229C991FAQ37984588-2B71A1AF-DDF0-437C-B949-DF56895D2446Q38132359-81C98510-9EF8-4CC9-B3E1-3267A44F8D95Q38343572-A1140F41-E257-47F2-BB94-3BD19EE82F46Q38353509-71C1EEF1-3DA5-4276-A9BB-967D3C34FF61Q38660093-EF795402-78B9-4122-86EB-8DFDAC876DB1Q38675161-9CF8B8E7-1ADC-4B89-ADC3-658499D536ADQ39106943-382CBB85-76A0-4A80-B4D1-A143792C710AQ39389106-55F27337-3751-4C08-AB95-64FD0A72E889Q42995833-07283FDF-BD4D-4E70-ACF8-8FBC3AED6342Q47143199-674C4EE1-97B1-4681-ABB5-7B9388CB3353
P2860
Silencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1, nuclear factor-kappaB, p53, bax, and p27 levels.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Silencing Bcl-2 in models of m ...... paB, p53, bax, and p27 levels.
@en
type
label
Silencing Bcl-2 in models of m ...... paB, p53, bax, and p27 levels.
@en
prefLabel
Silencing Bcl-2 in models of m ...... paB, p53, bax, and p27 levels.
@en
P2093
P1476
Silencing Bcl-2 in models of m ...... ppaB, p53, bax, and p27 levels
@en
P2093
Alastair H Kyle
Anita I Kapanen
Brad G Hoffman
Catherine A Tucker
Dana Masin
Ghania Chikh
Ian M Wilson
Richard J Klasa
P304
P356
10.1158/1535-7163.MCT-07-0302
P577
2008-03-28T00:00:00Z